RECENT NEWS
Benzinga  49 min ago  Comment 
AXIM Biotechnologies (OTC: AXIM), developers of cannabinoid-based pharmaceutical and cosmetic products, announced the production of CanChew Plus. CanChew Plus is an upgrade from AXIM's original CanChew, which the company calls "the most...
Forbes  7 hrs ago  Comment 
Could a specific, temporary low-calorie diet activate pre-natal gene codes to grow beta or β-cells? ...This could have a profound impact on your health, life span… and bank account.
Motley Fool  Feb 28  Comment 
Biotech stocks are known for their high growth, but they can also be toxic for your portfolio if you don't invest wisely.
Motley Fool  Feb 28  Comment 
The biotechnology giant was the first of its peers to pay a dividend, but can it keep impressing shareholders?
Motley Fool  Feb 28  Comment 
Will this past failure lead to a future success story?
Motley Fool  Feb 27  Comment 
Today was a good day for biotech stocks across the board, including Alnylam Pharmaceuticals.
newratings.com  Feb 27  Comment 
CANONSBURG (dpa-AFX) - The month of February saw the FDA approve the second drug for Duchenne muscular dystrophy namely Emflaza, which is also a novel drug. A novel drug refers to a new molecular entity that has never before been approved anywhere...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors




Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share

References

  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009 http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#

M&A Biotechnology http://knol.google.com/k/m-a-biotechnology#

http://knol.google.com/k/biotechnology-market-review-top-ten-biologics-2009#

Monoclonal Antibody Market 2009 http://knol.google.com/k/-/monoclonal-antibody-market-2009/3fy5eowy8suq3/86#

http://knol.google.com/k/new-drug-approvals-usa-fda-2009#

http://knol.google.com/k/new-drug-approvals-europe-ema-2009#

Vaccine Market 2009 http://knol.google.com/k/-/vaccine-market-2009/3fy5eowy8suq3/104#

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs) http://knol.google.com/k/global-monoclonal-antibodies-market-review-2008-world-top-ten-mabs#

M&A Review: Pharmaceutical & Biotechnology Industry http://knol.google.com/k/m-a-review-pharmaceutical-biotechnology-industry#

Global Vaccine Market Review 2008 (World Top Ten Vaccines) http://knol.google.com/k/global-vaccine-market-review-2008-world-top-ten-vaccines#


Ipilimumab (BMS) Review: A Cancer Breakthrough? http://knol.google.com/k/-/ipilimumab-bms-review-a-cancer/3fy5eowy8suq3/107#

Denosumab (Prolia, Amgen) FDA Review & Approval http://knol.google.com/k/-/denosumab-prolia-amgen-fda-review/3fy5eowy8suq3/60#

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki